Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide

导出原文传递

翻译打印收藏纠错

作者： G?hring,G. ^[1] ; Lange,K. ^[2] ; Hofmann,W. ^[3] ; Nielsen,K.V. ^[4] ; Hellstr?m-Lindberg,E. ^[5] ; Roy,L. ^[6] ; Morgan,M. ^[7] ; Kreipe,H. ; Büsche,G. ; Giagounidis,A. ; Schlegelberger,B.

作者单位： Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden ^[1] Department of Haematology, Oncology and Clinical Immunology, St Johannes Hospital, Duisburg, Germany ^[2] CHU de Poitiers, Centre de Recherche Clinique, Poitiers, France ^[3] Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical ^[4] Dako Denmark A/S, Glostrup, Denmark ^[5] Centre for Pathology and Forensic and Genetic Medicine, Institute of Pathology, Hannover Medical ^[6] Centre for Pathology and Forensic and Genetic Medicine, Institute of Cell and Molecular Pathology ^[7]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Leukemia

2012年26卷2期

356-358页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide

Leukemia

相似文献

Leukemia

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide

Leukemia

相似文献

Leukemia

相关期刊

检索历史清除